Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Roth

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Praxis|August 23, 2014
[Neurological complications in cancer patients]Thomas Hundsberger, Patrick Roth, Ulrich Roelcke
Procare : Das Forbildungsmagazin Fur Pflegeberufe|March 7, 2022
Anna Jerusalem, Kerstin Löffler, Patrick Roth
Current Opinion in Neurology|August 28, 2023
Immune checkpoint inhibitors induced side effects of the peripheral nervous systemThomas Hundsberger, Bettina Schreiner, Patrick Roth
Expert Opinion on Therapeutic Targets|January 23, 2021
A vasculature-centric approach to developing novel treatment options for glioblastomaHans-Georg Wirsching, Patrick Roth, Michael Weller
Chemotherapy|October 27, 2015
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade GliomaMichaela Tonder, Michael Weller, Günter Eisele, et al.
Neuro-Oncology Advances|October 10, 2022
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivoEvelina Blomberg, Manuela Silginer, Patrick Roth, et al.
Expert Review of Anticancer Therapy|May 19, 2012
Pathogenesis and management of primary CNS lymphomaPatrick Roth, Agnieszka Korfel, Peter Martus, et al.
Current Opinion in Neurology|October 5, 2011
Geriatric neuro-oncology: from mythology to biologyMichael Weller, Michael Platten, Patrick Roth, et al.
Cureus|September 15, 2022
Improving Patient Satisfaction in the Hispanic American CommunityMichael Kelson, Andrew Nguyen, Asaad Chaudhry, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Praxis|August 23, 2014
[Neurological complications in cancer patients]Thomas Hundsberger, Patrick Roth, Ulrich Roelcke
Procare : Das Forbildungsmagazin Fur Pflegeberufe|March 7, 2022
Anna Jerusalem, Kerstin Löffler, Patrick Roth
Current Opinion in Neurology|August 28, 2023
Immune checkpoint inhibitors induced side effects of the peripheral nervous systemThomas Hundsberger, Bettina Schreiner, Patrick Roth
Expert Opinion on Therapeutic Targets|January 23, 2021
A vasculature-centric approach to developing novel treatment options for glioblastomaHans-Georg Wirsching, Patrick Roth, Michael Weller
Chemotherapy|October 27, 2015
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade GliomaMichaela Tonder, Michael Weller, Günter Eisele, et al.
Neuro-Oncology Advances|October 10, 2022
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivoEvelina Blomberg, Manuela Silginer, Patrick Roth, et al.
Expert Review of Anticancer Therapy|May 19, 2012
Pathogenesis and management of primary CNS lymphomaPatrick Roth, Agnieszka Korfel, Peter Martus, et al.
Current Opinion in Neurology|October 5, 2011
Geriatric neuro-oncology: from mythology to biologyMichael Weller, Michael Platten, Patrick Roth, et al.
Cureus|September 15, 2022
Improving Patient Satisfaction in the Hispanic American CommunityMichael Kelson, Andrew Nguyen, Asaad Chaudhry, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
Pageof 23